test

ANDREW TIMPSON

@Silverarc Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters

Portfolio positions

This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KALVKalvista Pharmaceuticals Inc
Recent Activity
Increased 2.44%
1.5%
$6.653M
574,558 shares@ $11.59 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
New Position
1.49%
$6.6M
146,657 shares@ $45.0 avg price
SRPTSarepta Therapeutics Inc
Recent Activity
Increased 22.02%
1.44%
$6.4M
51,245 shares@ $124.89 avg price
BDSXBiodesix Inc
Recent Activity
Increased 96.86%
1.43%
$6.339M
3.561M shares@ $1.78 avg price
ELUTElutia Inc
Recent Activity
Increased 2.64%
1.41%
$6.271M
1.646M shares@ $3.81 avg price
ADCTAdc Therapeutics Sa
Recent Activity
Increased 1.49%
1.27%
$5.655M
1.795M shares@ $3.15 avg price
GOSSGossamer Bio Inc
Recent Activity
Increased 2.65%
1.26%
$5.569M
5.645M shares@ $0.99 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Decreased -16.78%
1.23%
$5.434M
455,082 shares@ $11.94 avg price
HLXBHelix Acquisition Corp Ii
Recent Activity
Increased 2.68%
1.21%
$5.365M
513,369 shares@ $10.45 avg price
ABVXAbivax Sa
Recent Activity
Increased 1.29%
1.2%
$5.318M
461,660 shares@ $11.52 avg price